FIM
UTHR icon

FWL Investment Management’s United Therapeutics UTHR Stock Holding History

FWL Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9K Sell
33
-41
-55% -$23.1K ﹤0.01% 270
2026
Q1 		$43.9K Sell
74
-66
-47% -$32.9K 0.01% 171
2025
Q4 		$68.2K Buy
140
+98
+233% +$45.6K 0.02% 139
2025
Q3 		$17.6K Buy
+42
New +$14.1K ﹤0.01% 209

Other funds holding UTHR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Norges Bank
Norges Bank Oslo, Norway $1T AUM

FWL Investment Management's UTHR Position: Q2 2026 in Review

FWL Investment Management reduced its United Therapeutics (UTHR) stake by 55% in Q2 2026, selling an estimated $23.1K and leaving 33 shares worth $17.9K. The position accounts for ﹤0.01% of the portfolio, ranked #270.

FWL Investment Management first reported a position in UTHR in Q3 2025 and has held it in 4 quarters since. The position peaked at $68.2K in Q4 2025. 884 funds tracked by Wall St. Rank hold UTHR as of Q2 2026.

  • FWL Investment Management held 33 shares of United Therapeutics worth $17.9K as of Q2 2026.
  • FWL Investment Management sold 41 United Therapeutics shares in Q2 2026, an estimated $23.1K.
  • United Therapeutics made up ﹤0.01% of FWL Investment Management's portfolio in Q2 2026, its #270 holding.
  • FWL Investment Management first reported a position in United Therapeutics in Q3 2025 and has held it in 4 quarters since.
  • FWL Investment Management's United Therapeutics position peaked at $68.2K in Q4 2025.
  • 884 funds tracked by Wall St. Rank held United Therapeutics as of Q2 2026.

Based on FWL Investment Management's 13F filing for Q2 2026, filed 14 Aug 2026.